The $250 million registered direct offering announced by Rezolve AI PLC (RZLV) on January 20, 2026, significantly impacts the company's cash position and its strategic path toward achieving Q2 2026 EBITDA break-even.
Impact on Cash Burn Rate
The offering involved the sale of 62,500,000 ordinary shares at a purchase price of $4.00 per share, resulting in gross proceeds of approximately $250 million.1 This substantial capital infusion directly bolsters Rezolve AI's liquidity. Prior to this offering, the company reported an "Ample liquidity position with ~$120 million in cash to support growth & strategic initiatives."2 The additional $250 million significantly extends the company's cash runway, providing a substantial buffer against operational expenditures and reducing immediate concerns about cash burn. The net proceeds are intended for accelerated investment into the sales organization, potential accretive M&A opportunities, and general corporate and working capital purposes.1 While these investments may lead to increased operational expenses in the short term, the enhanced cash reserves provide the financial flexibility to fund these growth initiatives without immediately depleting working capital.
Path to Q2 2026 EBITDA Break-even
The capital raised from this offering is a critical enabler for Rezolve AI's stated goal of achieving "Adjusted EBITDA break-even targeted for Q2 2026."2 While the offering itself does not directly generate EBITDA, it provides the necessary financial resources to execute the strategies designed to reach profitability. Specifically, the planned "accelerated investment into its sales organization"1 is crucial for driving revenue growth, which is a primary factor in achieving EBITDA break-even. The enhanced liquidity also provides resilience, allowing the company to navigate market fluctuations or unexpected operational costs without derailing its profitability timeline. This financial strengthening supports the company's strategic roadmap and increases the probability of hitting its Q2 2026 Adjusted EBITDA break-even target.
